Health & Biotech
ASX Health Stocks: Patrys to commence Phase 1 trial as drug production process put in motion
Prominent Perth fundie the main backer in PharmAust’s $3.5m cap raise
Melodiol’s FY23 revenue exceeds $20m as acquisition strategy proves successful
ASX Health Stocks: Island Pharma advances anti-viral study; Compumedics scores $9.3m order in China
Which companies could make the gains amid a pumping global fitness sector?
ASX Health Stocks: The secret is out – Chemist Warehouse plans ASX listing via Sigma healthcare merger
InteliCare inks multi-million dollar binding reseller agreement and aged care deployment
ScoPo’s Powerplays: ASX health stocks lift, as Paragon Care up 16pc on EBOS takeover speculation
Stock Insiders: Aroa Biosurgery isn’t wasting time counting sheep
ASX Health Stocks: Oncosil advances pancreatic cancer device to Greece, its third potential market in Europe
Huge IPO interest and not lithium? LTR Pharma could be the next big thing on the ASX
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
The ASX stocks hoping to profit from the endless search for an ‘elixir of youth’
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
ASX Health Stocks: Imugene wins ‘intention to grant’ cancer vaccine patent, Phase 2 trial in 2024
PharmAust bolsters leadership as CEO attends global ALS/MND Symposium
ASX Health Stocks: Neuren Pharma to begin Phase 2 clinical trial of children with Pitt Hopkins syndrome
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
